Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew S Block

Showing results (11-20 of 117) with videos related to

Pageof 12
Sort By:
Journal of Surgical Oncology|December 15, 2018
Management of local or regional non-nodal diseaseJennifer M Racz, Matthew S Block, Christian L Baum, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2011
Differential response of human and mouse dendritic cells to VEGF determines interspecies discrepancies in tumor-mediated TH1/TH2 polarity shiftMatthew S Block, Wendy K Nevala, Alexey A Leontovich, et al.
Muscle & Nerve|April 12, 2017
Facial diplegia after pembrolizumab treatmentMicah D Yost, Claudia Z Chou, Hugo Botha, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2003
MHC class I gene conversion mutations alter the CD8 T cell repertoireMatthew S Block, Michael J Hansen, Virginia P Van Keulen, et al.
Physical Review Letters|May 17, 2011
Spin Bose-metal and valence bond solid phases in a spin-1/2 model with ring exchanges on a four-leg triangular ladderMatthew S Block, D N Sheng, Olexei I Motrunich, et al.
Annals of Surgical Oncology|November 26, 2021
Surgeon Assessment of the Technical Impact of Neoadjuvant Systemic Therapy on Operable Stage III MelanomaTina J Hieken, Daniel L Price, Mara A Piltin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2005
Direct cross-priming by th lymphocytes generates memory cytotoxic T cell responsesRichard Kennedy, Anita H Undale, William C Kieper, et al.
Annals of Surgical Oncology|August 26, 2025
Accuracy of PET-CT to Assess the Extent of Nodal Disease in Patients with Clinical Stage III Melanoma Following Neoadjuvant TreatmentRonen Stoff, Mariana Yalon, Matthew P Thorpe, et al.
Therapeutic Advances in Medical Oncology|January 22, 2026
Biomarker analysis of circulating tumor DNA in clinical stage III melanoma patients treated with neoadjuvant immunotherapy combined with targeted therapyRonen Stoff, David M Routman, Mariana Yalon, et al.
Melanoma Research|December 7, 2018
A pilot clinical trial testing topical resiquimod and a xenopeptide as immune adjuvants for a melanoma vaccine targeting MART-1Matthew S Block, Wendy K Nevala, Yuan-Ping Pang, et al.
Pageof 12

Showing results (11-20 of 117) with videos related to

Sort By:
Pageof 12
Journal of Surgical Oncology|December 15, 2018
Management of local or regional non-nodal diseaseJennifer M Racz, Matthew S Block, Christian L Baum, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2011
Differential response of human and mouse dendritic cells to VEGF determines interspecies discrepancies in tumor-mediated TH1/TH2 polarity shiftMatthew S Block, Wendy K Nevala, Alexey A Leontovich, et al.
Muscle & Nerve|April 12, 2017
Facial diplegia after pembrolizumab treatmentMicah D Yost, Claudia Z Chou, Hugo Botha, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2003
MHC class I gene conversion mutations alter the CD8 T cell repertoireMatthew S Block, Michael J Hansen, Virginia P Van Keulen, et al.
Physical Review Letters|May 17, 2011
Spin Bose-metal and valence bond solid phases in a spin-1/2 model with ring exchanges on a four-leg triangular ladderMatthew S Block, D N Sheng, Olexei I Motrunich, et al.
Annals of Surgical Oncology|November 26, 2021
Surgeon Assessment of the Technical Impact of Neoadjuvant Systemic Therapy on Operable Stage III MelanomaTina J Hieken, Daniel L Price, Mara A Piltin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2005
Direct cross-priming by th lymphocytes generates memory cytotoxic T cell responsesRichard Kennedy, Anita H Undale, William C Kieper, et al.
Annals of Surgical Oncology|August 26, 2025
Accuracy of PET-CT to Assess the Extent of Nodal Disease in Patients with Clinical Stage III Melanoma Following Neoadjuvant TreatmentRonen Stoff, Mariana Yalon, Matthew P Thorpe, et al.
Therapeutic Advances in Medical Oncology|January 22, 2026
Biomarker analysis of circulating tumor DNA in clinical stage III melanoma patients treated with neoadjuvant immunotherapy combined with targeted therapyRonen Stoff, David M Routman, Mariana Yalon, et al.
Melanoma Research|December 7, 2018
A pilot clinical trial testing topical resiquimod and a xenopeptide as immune adjuvants for a melanoma vaccine targeting MART-1Matthew S Block, Wendy K Nevala, Yuan-Ping Pang, et al.
Pageof 12